Eisaku Miyauchi

Long noncoding <scp>RNA </scp><i><scp>HOTAIR</scp></i> is relevant to cellular proliferation, invasiveness, and clinical relapse in small‐cell lung cancer

Hiroshi Ono, Noriko Motoi, Hiroko Nagano et al. · Cancer Medicine · 2014 · 137 citations · Full text

Updated Analysis of NEJ009: Gefitinib-Alone Versus Gefitinib Plus Chemotherapy for Non–Small-Cell Lung Cancer With Mutated <i>EGFR</i>

Eisaku Miyauchi, Satoshi Morita, Atsushi Nakamura et al. · Journal of Clinical Oncology · 2022 · 89 citations · Full text

Plasma or Serum: Which Is Preferable for Mutation Detection in Liquid Biopsy?

Fábio Pittella Silva, Yoon Ming Chin, Ting Chan et al. · Clinical Chemistry · 2020 · 68 citations · Full text

Real-world survey of pneumonitis and its impact on durvalumab consolidation therapy in patients with non-small cell lung cancer who received chemoradiotherapy after durvalumab approval (HOPE-005/CRIMSON)

Go Saito, Yuko Oya, Yoshihiko Taniguchi et al. · Lung Cancer · 2021 · 53 citations

Durvalumab Consolidation Therapy, Medicine, Metronomic Therapy +9

Distinct Characteristics of Small Cell Lung Cancer Correlate With Central or Peripheral Origin

Eisaku Miyauchi, Noriko Motoi, Hiroshi Ono et al. · Medicine · 2015 · 40 citations · Full text